Number of the records: 1  

HPMA-based macromolecular therapeutics reinforce anti-tumor immunity

  1. 1.
    0099657 - MBÚ 2008 RIV GB eng C - Conference Paper (international conference)
    Šírová, Milada - Mrkvan, Tomáš - Strohalm, Jiří - Etrych, Tomáš - Ulbrich, Karel - Říhová, Blanka
    HPMA-based macromolecular therapeutics reinforce anti-tumor immunity.
    [Makromolekulární léčiva na bázi HPMA posilují imunitu proti nádoru.]
    Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. London: Karger, 2007, s. 86-86. ISSN 1010-4283.
    [Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. Prague (CZ), 15.09.2007-19.09.2007]
    R&D Projects: GA AV ČR KAN200200651
    Institutional research plan: CEZ:AV0Z50200510; CEZ:AV0Z40500505
    Keywords : doxorubicin
    Subject RIV: EC - Immunology

    Results of the anti-tumour efficace of several types of HPMA-based copolymer conjugates of doxorubicin; study focused on the anti-tumour immune responses of the host

    Výsledky testování protinádorové účinnosti několika typů konjugátů na bázi HPMA, obsahujících doxorubicin; studie se soustředí na imunitní reakci hostitele proti nádoru
    Permanent Link: http://hdl.handle.net/11104/0158208

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.